Pfizer Inc. (PFE)
NYSE: PFE · Real-Time Price · USD
25.01
+0.10 (0.40%)
At close: Jul 31, 2026, 4:00 PM EDT
25.04
+0.03 (0.12%)
After-hours: Jul 31, 2026, 7:59 PM EDT
Pfizer Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 63,315 | 62,579 | 63,627 | 59,553 | 101,175 | 81,288 |
Revenue Growth | 1.36% | -1.65% | 6.84% | -41.14% | 24.46% | 95.17% |
Gross Profit Gross Profit Growth | 46,545 | 46,512 | 45,776 | 34,599 | 66,831 | 50,467 |
Operating Income Operating Income Growth | 7,905 | 7,520 | 8,023 | 1,057 | 34,727 | 24,311 |
Net Income Net Income Growth | 7,490 | 7,771 | 8,031 | 2,119 | 31,372 | 21,979 |
Earnings Per Share EPS Growth | 1.31 | 1.36 | 1.41 | 0.37 | 5.47 | 3.85 |
EPS Growth | -5.07% | -3.55% | 281.08% | -93.24% | 42.08% | 226.27% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Primary Care Primary Care Growth | 26,666 | 26,820 | 30,135 | 30,799 | 73,181 | 52,029 |
Specialty Care Specialty Care Growth | - | 17,546 | 16,652 | 14,988 | 13,851 | 15,194 |
Oncology Oncology Growth | - | 16,834 | 15,612 | 12,450 | 12,794 | 12,333 |
Business Innovation (Pfizer CentreOne) Business Innovation (Pfizer CentreOne) Growth | 1,370 | 1,338 | 1,146 | 1,272 | 1,342 | 1,731 |
Revenue (Total) Revenue (Total) Growth | 63,315 | 62,579 | 63,627 | 59,553 | 101,175 | 81,288 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 13,075 | 13,596 | 20,477 | 12,690 | 22,732 | 31,069 |
Total Debt Total Debt Growth | 64,455 | 64,795 | 64,351 | 71,888 | 35,829 | 38,436 |
Net Cash (Debt) Net Cash Growth | -51,380 | -51,199 | -43,874 | -59,198 | -13,097 | -7,367 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -8.99 | -8.96 | -7.70 | -10.37 | -2.28 | -1.29 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 11,984 | 11,704 | 12,744 | 8,700 | 29,267 | 32,580 |
Capital Expenditures CapEx Growth | -2,501 | -2,629 | -2,909 | -3,907 | -3,236 | -2,711 |
Free Cash Flow Free Cash Flow Growth | 9,483 | 9,075 | 9,835 | 4,793 | 26,031 | 29,869 |
Free Cash Flow Growth | -15.48% | -7.73% | 105.19% | -81.59% | -12.85% | 145.29% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 73.51% | 74.33% | 71.94% | 58.10% | 66.05% | 62.08% |
Operating Margin | 12.49% | 12.02% | 12.61% | 1.77% | 34.32% | 29.91% |
Pretax Margin | 12.49% | 12.02% | 12.61% | 1.78% | 34.33% | 29.91% |
Profit Margin | 11.88% | 12.44% | 12.65% | 3.65% | 31.04% | 27.63% |
FCF Margin | 14.98% | 14.50% | 15.46% | 8.05% | 25.73% | 36.74% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 1, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 1.720 | 1.720 | 1.680 | 1.640 | 1.600 | 1.560 |
Dividend Per Share Growth | 0.58% | 2.38% | 2.44% | 2.50% | 2.56% | 2.63% |
Dividend Yield | 6.88% | 6.90% | 6.33% | 5.69% | 3.13% | 2.64% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 1, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 19.08 | 18.31 | 18.82 | 77.81 | 9.37 | 15.34 |
Forward PE | 8.76 | 8.54 | 9.91 | 19.25 | 10.82 | 10.64 |
P/FCF Ratio | 15.03 | 15.60 | 15.29 | 33.91 | 11.05 | 11.11 |
PS Ratio | 2.25 | 2.26 | 2.36 | 2.73 | 2.84 | 4.08 |